Dosage, titration, and gaps in treatment with extended release niacin in clinical practice

By Kamal-Bahl Sachin J.   Burke Thomas A.   Watson Douglas J.   Wentworth Charles E.  

Current Medical Research and Opinion, Vol. 24, Iss. 6, 2008-06 ,pp. : 1817-1821

Informa Healthcare

Access to resources Recommend Favorite

A comparison of the pharmacokinetics of two different formulations of extended-release niacin

By Lauring B.   Rosko K.   Luo W.-L.   Wenning L.   Kissling J.   Roupe K.   Paolini J. F.   Wagner J.   Lai E.  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 15-22

Informa Healthcare

Access to resources Recommend Favorite

Determinants of lipid goal achievement in patients on extended-release nicotinic acid/laropiprant in primary care clinical practice

By Dänschel Wilfried   Steinhagen-Thiessen Elisabeth   Buffleben Claudia   Pittrow David   Hildemann Steven K.  

Current Medical Research and Opinion, Vol. 29, Iss. 1, 2013-01 ,pp. : 33-40

Informa Healthcare

Access to resources Recommend Favorite

Clinical application of extended-release hydromorphone for pain management

By Grider Jay S  

Therapy, Vol. 6, Iss. 5, 2009-09 ,pp. : 653-656

Future Medicine

Access to resources Recommend Favorite

The effect of 24 months of combination statin and extended-release niacin on carotid intima–media thickness: ARBITER 3

By Taylor Allen J.   Lee Hyun J.   Sullenberger Lance E.  

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2243-2250

Informa Healthcare

Access to resources Recommend Favorite